Fibromyalgia Syndrome (FMS)

Fibromyalgia Syndrome (FMS)
Presentation by:Mini-Med School 2007

Raymond H. Flores, MD, FACR
Department of Medicine
Division of Rheumatology & Clinical Immunology


Topics covered

* What is Fibromyalgia (FMS)?
* What causes it?
* Who gets it?
* How is it diagnosed?
* How is it treated?
* What are some of the common misconceptions about the syndrome?

What causes FMS?
Who gets FMS?
How is FMS diagnosed?
ACR classification criteria: fibromyalgia
Fibromyalgia: tender points
How is FMS treated?
Other Therapies for FMS

Fibromyalgia Syndrome (FMS).ppt

Read more...

Rheumatological Urgencies

Rheumatological Urgencies
Presentation by: Rochella Ostrowski

Medical History
Physical Exam
DDX

* Crystal induced arthritis (Gout, pseudogout)
* Septic arthritis
X ray L foot
Arthrocentesis
Polarizing Microscopy
Synovial Fluid
Gout
Gout Treatment
Indications for Chronic therapy of Gout
Which diagnostic tests would you order next?
Septic Arthritis
Gonococcal vs Non-gonococcal
Organisms in Septic Arthritis
Mechanisms of Joint infection
Conditions That Predispose a Patient to Joint Infections
Septic Arthritis Therapy
Giant Cell Arteritis
GCA Clinical Findings
Treatment of GCA
Most reasonable diagnoses?

* Giant Cell Arteritis
* Rheumatoid arthritis
* Polymyositis
* Dermatomyositis
* Sjogren’s syndrome
* Ankylosing spondylitis
* Primary Raynaud’s
* Scleroderma
* Systemic lupus erythematosus

Scleroderma
Periungual Erythema
Nailfold Capillaroscopy
Scleroderma Diagnosis and Treatment
Scleroderma Renal Crisis
Manifestations of Scleroderma Renal Crisis
SRC Risk Factors
SRC Therapy
Diagnostic Tests

Rheumatological Urgencies.ppt

Read more...

Newer Anticoagulant Therapies

Newer Anticoagulant Therapies
Presentation by:Chris Ferrell MT(ASCP), CLS/H(NCA)

Special Coagulation Lead
Harborview Medical Center
University of Washington

Heparin Therapy
Lupus Anticoagulant and PTT
Monitoring Heparin Therapy in Patients with LA
Warfarin Therapy
Lupus Anticoagulant and Protime
Monitoring Coumadin Therapy in Patients with LA
Low Molecular Weight Heparin
Antithrombin
Thrombin
Unfractionated Heparin
Pentasaccharide
Antithrombin
Factor Xa
Pentasaccharide
LMWH Comparisons
Tinzaparin
Reviparin
Nadroparin
Enoxaparin
Dalteparin
Ardeparin
Advantages
FDA Approved Indications of LMWHs
Total knee replacement
Total hip replacement
General surgery
LMWH Administration
PTT and LWMH
LMWH Comparisons
Low Molecular Weight Heparin
Other Tests to Monitor Heparin
Problems with Monitoring Heparin Therapy with PTT’s
Why Use LMWH vs. UFH?
Heparin Induced Thrombocytopenia
What Is It?
Heparin Induced Thrombocytopenia
HIT Testing
How Do You Diagnose It?
HIT Testing by Aggregometry
Light source
Positive HIT Test
Patient Plasma
Heparin Induced Thrombocytopenia
Advances in Anticoagulation
Direct Thrombin Inhibitors
Hirudin and Derivatives
Thrombin and Hirudin
Direct Thrombin Inhibitors
Hirudin and Derivatives
Direct Thrombin Inhibitors Hirudin and Derivatives
Direct Thrombin Inhibitors
Clinical Trials of Direct Thrombin Inhibitors
Direct Thrombin Inhibitors
Effect on Laboratory Testing
Low Molecular Weight Heparin
Fondaparinux
Inhibition of VIIa/TF
Tissue Factor Pathway Inhibitor
Enhanced Protein C Pathway
Enhancement of the fibrinolysis
Advances in Anticoagulation
Platelet Function Inhibitors
Ideal Anticoagulant

Newer Anticoagulant Therapies,ppt

Read more...